tiprankstipranks
pc:hum3x

Humanix

San Francisco, CA 94103, US
https://www.humanix.ai/
Cybersecurity
Humanix is redefining cybersecurity by making the human layer visible and defensible, closing the last major blind spot: social engineering. Using AI-powered natural language analysis, Humanix detects and blocks these attacks in real-time across help desks, service desks, and customer-facing channels.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$18M
Total Amount Raised$18M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$18M
Latest Funding Amount$18M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 12, 2025
Series A
$18.00M
―

Investors

Investor Name
Funding Round
Acrew Capital
Series A
boldstart ventures
Series A

Related News and Analysis

Humanix Highlights Hidden Breach Risk in Low-Severity Security Alerts

Humanix Highlights Hidden Breach Risk in Low-Severity Security Alerts

According to a recent LinkedIn post from Humanix, the company is drawing attention to research from Intezer indicating...
6d ago
HUM3X
Teleskope Launches Native Slack Integration to Automate Data Exposure Remediation

Teleskope Launches Native Slack Integration to Automate Data Exposure Remediation

New updates have been reported about Teleskope. Teleskope has introduced a native Slack integration aimed at closing a...
2h ago
TELES
Glacis Labs Secures $6.8 Million Seed Round to Scale ZeroDelta On-Chain Clearing

Glacis Labs Secures $6.8 Million Seed Round to Scale ZeroDelta On-Chain Clearing

New updates have been reported about Glacis Labs. Glacis Labs has raised $6.8 million in seed financing to...
3h ago
GLACI
SpinaFX wins CE Mark for Triojection, opening EU commercialization and global growth path

SpinaFX wins CE Mark for Triojection, opening EU commercialization and global growth path

New updates have been reported about SpinaFX Medical Inc. SpinaFX Medical Inc., a Toronto-based private medtech company, has...
3h ago
SPINA
Thyme Care Reshapes Leadership to Scale Oncology Platform and Launch New Business Lines

Thyme Care Reshapes Leadership to Scale Oncology Platform and Launch New Business Lines

New updates have been reported about Thyme Care. Thyme Care is advancing its growth strategy with a leadership...
4h ago
THYME
FalconX Buys bloXroute to Speed Institutional Shift to Onchain Capital Markets

FalconX Buys bloXroute to Speed Institutional Shift to Onchain Capital Markets

New updates have been reported about FalconX. FalconX has acquired blockchain networking specialist bloXroute, a move that consolidates...
5h ago
FALCX
Autonomize AI Launches Healthcare-Native Genie AI Agent to Put Workflow Design in Clinicians’ Hands

Autonomize AI Launches Healthcare-Native Genie AI Agent to Put Workflow Design in Clinicians’ Hands

New updates have been reported about Autonomize AI. Autonomize AI has unveiled Autonomize Genie AI, a healthcare-native AI...
5h ago
AUTON
TytoCare Raises Over $25M and Names New CEO to Scale AI-Driven Clinical Enablement Platform

TytoCare Raises Over $25M and Names New CEO to Scale AI-Driven Clinical Enablement Platform

New updates have been reported about TytoCare. TytoCare has appointed digital health veteran Adam Pellegrini as chief executive...
6h ago
TYTOC
FAVE Secures Seed Funding and Nationwide Sprouts Launch to Disrupt $1 Billion Drink Mix Market

FAVE Secures Seed Funding and Nationwide Sprouts Launch to Disrupt $1 Billion Drink Mix Market

New updates have been reported about FAVE. FAVE, an organic drink mix company targeting the nearly $1 billion...
6h ago
FAVEX
G50 Corp Reports Breakthrough Metallurgical Results at Golconda, Doubling Gallium Grades

G50 Corp Reports Breakthrough Metallurgical Results at Golconda, Doubling Gallium Grades

New updates have been reported about G50 Corp Limited. G50 Corp Limited has reported Phase 2 metallurgical results...
6h ago
GCORP